Prostate Cancer International is a
non-profit for 2012 as rated by Great NonProfits
We have now been able to track down a link to detailed information about the article by Yu et al. referred to in yesterday’s commentary under the same heading. … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: aggressive, CNV, copy number variation, progression, risk | 2 Comments »
Another new test — this time (supposedly) reported on-line in the American Journal of Pathology (and scheduled for publication in the June issue of that journal) — has suggested that monitoring genetic variation may be helpful in predicting risk from specific types of prostate cancer. If one is to believe the report in today’s Pittsburgh Post-Gazette, the new test ‘could represent “the Holy Grail of prostate cancer” by specifying from the start whether aggressive treatment is necessary’ … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Risk | Tagged: CNV, copy number variation, genetics | 1 Comment »
Search for new and
ongoing trials on the
CTAG PCa web site